Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67,017,829
-
Total 13F shares
-
57,297,209
-
Share change
-
-83,311
-
Total reported value
-
$315,134,256
-
Put/Call ratio
-
540%
-
Price per share
-
$5.50
-
Number of holders
-
81
-
Value change
-
+$379,810
-
Number of buys
-
39
-
Number of sells
-
39
Institutional Holders of Generation Bio Co. - #OTHER (GBIO) as of Q2 2023
As of 30 Jun 2023,
Generation Bio Co. - #OTHER (GBIO) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,297,209 shares.
The largest 10 holders included
FMR LLC, Atlas Venture Life Science Advisors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Bellevue Group AG, BlackRock Inc., T. Rowe Price Investment Management, Inc., Artal Group S.A., PFM Health Sciences, LP, VANGUARD GROUP INC, and EcoR1 Capital, LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.